UBS Group’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.6M | Buy |
916,977
+84,189
| +10% | +$975K | ﹤0.01% | 2377 |
|
2025
Q1 | $7.27M | Buy |
832,788
+569,261
| +216% | +$4.97M | ﹤0.01% | 2651 |
|
2024
Q4 | $3.78M | Buy |
263,527
+18,773
| +8% | +$270K | ﹤0.01% | 3223 |
|
2024
Q3 | $5.53M | Buy |
244,754
+93,197
| +61% | +$2.1M | ﹤0.01% | 2193 |
|
2024
Q2 | $2.95M | Buy |
151,557
+97,290
| +179% | +$1.89M | ﹤0.01% | 2524 |
|
2024
Q1 | $2.04M | Buy |
54,267
+48,038
| +771% | +$1.8M | ﹤0.01% | 2973 |
|
2023
Q4 | $349K | Sell |
6,229
-4,882
| -44% | -$273K | ﹤0.01% | 4234 |
|
2023
Q3 | $458K | Buy |
11,111
+1,228
| +12% | +$50.7K | ﹤0.01% | 3670 |
|
2023
Q2 | $552K | Sell |
9,883
-12,589
| -56% | -$703K | ﹤0.01% | 3745 |
|
2023
Q1 | $1.25M | Buy |
22,472
+17,575
| +359% | +$981K | ﹤0.01% | 2995 |
|
2022
Q4 | $178K | Buy |
4,897
+3,029
| +162% | +$110K | ﹤0.01% | 4460 |
|
2022
Q3 | $53K | Sell |
1,868
-1,065
| -36% | -$30.2K | ﹤0.01% | 5241 |
|
2022
Q2 | $132K | Sell |
2,933
-21,008
| -88% | -$945K | ﹤0.01% | 4231 |
|
2022
Q1 | $1.82M | Sell |
23,941
-7,150
| -23% | -$544K | ﹤0.01% | 2732 |
|
2021
Q4 | $4.63M | Buy |
31,091
+2,049
| +7% | +$305K | ﹤0.01% | 2165 |
|
2021
Q3 | $4.23M | Buy |
29,042
+4,245
| +17% | +$618K | ﹤0.01% | 2159 |
|
2021
Q2 | $4.86M | Sell |
24,797
-5,530
| -18% | -$1.08M | ﹤0.01% | 2042 |
|
2021
Q1 | $5.49M | Sell |
30,327
-6,145
| -17% | -$1.11M | ﹤0.01% | 1872 |
|
2020
Q4 | $5.17M | Sell |
36,472
-27,980
| -43% | -$3.96M | ﹤0.01% | 1819 |
|
2020
Q3 | $8.04M | Buy |
64,452
+30,471
| +90% | +$3.8M | ﹤0.01% | 1408 |
|
2020
Q2 | $3.04M | Buy |
33,981
+5,622
| +20% | +$502K | ﹤0.01% | 1962 |
|
2020
Q1 | $1.77M | Buy |
28,359
+4,160
| +17% | +$259K | ﹤0.01% | 2251 |
|
2019
Q4 | $1.84M | Buy |
24,199
+23,162
| +2,234% | +$1.76M | ﹤0.01% | 2839 |
|
2019
Q3 | $52K | Buy |
+1,037
| New | +$52K | ﹤0.01% | 5239 |
|